VRAYQ (ViewRay) Ending Cash Position: $85.5 Mil (As of Mar. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VRAYQ ViewRay Inc VRAYQ
12 GF Score
Price $0.00
View Full Analysis

What is ViewRay Ending Cash Position?

ViewRay VRAYQ -99.00% 12 Ending Cash Position is $85.5 Mil as of Mar. 2023. GuruFocus rates VRAYQ with a GF Score™ of 12/100.

ViewRay's Ending Cash Position for the quarter that ended in Mar. 2023 was $85.5 Mil.

ViewRay's quarterly Ending Cash Position declined from Sep. 2022 ($146.9 Mil) to Dec. 2022 ($142.5 Mil) and declined from Dec. 2022 ($142.5 Mil) to Mar. 2023 ($85.5 Mil).

ViewRay's annual Ending Cash Position increased from Dec. 2020 ($158.2 Mil) to Dec. 2021 ($219.8 Mil) but then declined from Dec. 2021 ($219.8 Mil) to Dec. 2022 ($142.5 Mil).

ViewRay Ending Cash Position Related Terms

ViewRay Ending Cash Position Historical Data

* Premium members only.

The historical data trend for ViewRay's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViewRay Ending Cash Position Chart

ViewRay Annual Data
Trend Nov13 Nov14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 169.37 228.19 158.18 219.81 142.50

ViewRay Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 184.66 162.19 146.87 142.50 85.53
VRAYQ
12GF Score
ViewRay Inc VRAYQ
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ViewRay Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

ViewRay's Ending Cash Position for the fiscal year that ended in Dec. 2022 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=219.808+-77.313
=142.5

ViewRay's Ending Cash Position for the quarter that ended in Mar. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=142.495+-56.961
=85.5

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $85.5 Mil mean?
ViewRay (VRAYQ) has a Ending Cash Position of $85.5 Mil as of Mar. 2023. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on ViewRay and its competitors.
Is ViewRay's Ending Cash Position too high?
ViewRay's current Ending Cash Position is $85.5 Mil. Overall, ViewRay has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does ViewRay's Ending Cash Position compare to NNMX and RTSL?
ViewRay's Ending Cash Position of $85.5 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Medical Devices & Instruments company?
A good Ending Cash Position depends on the Medical Devices & Instruments industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on ViewRay and its competitors. ViewRay's current Ending Cash Position is $85.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViewRay stock overvalued right now?
ViewRay (VRAYQ) has a current Ending Cash Position of $85.5 Mil. The current Ending Cash Position is $85.5 Mil. ViewRay's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For ViewRay (VRAYQ), the current Ending Cash Position is $85.5 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ViewRay Business Description

Address 2 Thermo Fisher Way, Oakwood Village, OH, USA, 44146
ViewRay Inc designs, manufactures and markets MRIdian, an MR Image-Guided radiation therapy system to simultaneously image and treat cancer patients. MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that may arise when high magnetic fields interact with radiation beams.
12GF Score

Get the complete analysis for VRAYQ

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price